Cargando…

Pembrolizumab-induced optic neuropathy – a case report

BACKGROUND: Immune checkpoint inhibitor (ICI) treatment has become important for treating various cancer types, including Hodgkin’s lymphoma. However, ICI can overstimulate the immune system, leading to a broad range of immunological side effects, known as immune-related adverse events (irAEs). Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daetwyler, Eveline, Zippelius, Alfred, Meyer, Peter, Läubli, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203429/ https://www.ncbi.nlm.nih.gov/pubmed/37228591 http://dx.doi.org/10.3389/fimmu.2023.1171981

Ejemplares similares

Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options
por: Daetwyler, Eveline, et al.
Publicado: (2023)

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015)

Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023)

Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis
por: Nishiyama, Kazuhiro, et al.
Publicado: (2023)

Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020)

Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
por: Ortega Sanchez, Guacimara, et al.
Publicado: (2018)

Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
por: Läubli, Heinz, et al.
Publicado: (2019)

Editorial: Novel roles for tumor-associated neutrophils
por: Mandruzzato, Susanna, et al.
Publicado: (2022)

Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies
por: Trüb, Marta, et al.
Publicado: (2021)

Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature
por: Bruno, Francesco, et al.
Publicado: (2021)

Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series
por: McCormack, Sean M, et al.
Publicado: (2023)

Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
por: Martin, Kea, et al.
Publicado: (2015)

Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report
por: Jabkowski, Jörg, et al.
Publicado: (2021)

Editorial: Glycans: Masters of immunity, from cancers to inflammatory disease
por: Beatson, Richard, et al.
Publicado: (2022)

Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
por: Läubli, Heinz, et al.
Publicado: (2017)

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma
por: Kao, Chien-Hsiang, et al.
Publicado: (2022)

Case report: Local cryoablation combined with pembrolizumab to eliminate lung metastases from ovarian clear cell carcinoma
por: Meng, Liangliang, et al.
Publicado: (2022)

Case report: The remarkable response of pembrolizumab combined with RC48 in the third-line treatment of metastatic urothelial carcinoma
por: Xu, Zhenying, et al.
Publicado: (2022)

Multiple Cranial Neuropathies Similar to Orbital Apex Syndrome Associated with Pembrolizumab: A Case Report
por: Nishimura, Taku, et al.
Publicado: (2022)

Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy
por: Jiang, Shuhong, et al.
Publicado: (2020)

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
por: Zhang, Wei, et al.
Publicado: (2023)

Presumed clomiphene-induced optic neuropathy: A case report
por: Alizadeh, Yousef, et al.
Publicado: (2021)

Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
por: Tian, Wentao, et al.
Publicado: (2023)

Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression
por: Wu, Dingyong, et al.
Publicado: (2021)

Pembrolizumab-Induced Hypothyroidism: A Case Report
por: Gaibor, Carlos, et al.
Publicado: (2023)

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy
por: De Matteis, Serena, et al.
Publicado: (2022)

Hydroxychloroquine: Optic neuropathy: case report
Publicado: (2021)

Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer
por: Dettwiler, Dimitri, et al.
Publicado: (2023)

Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies
por: Heming, Michael, et al.
Publicado: (2019)

Immune-Therapy-Related Toxicity Events and Dramatic Remission After a Single Dose of Pembrolizumab Treatment in Metastatic Thymoma: A Case Report
por: Shen, Li, et al.
Publicado: (2021)

Neuroinflammation, Microglia and Implications for Retinal Ganglion Cell Survival and Axon Regeneration in Traumatic Optic Neuropathy
por: Au, Ngan Pan Bennett, et al.
Publicado: (2022)

Presumed Chemotherapy-Induced Optic Neuropathy and Maculopathy: A Case Report
por: Mathew, David J., et al.
Publicado: (2017)

Durable Metastatic Melanoma Remission Following Pembrolizumab and Radiotherapy: A Case Report of Prophylactic Immunosuppression in a Patient with Myasthenia Gravis and Immune-Mediated Colitis
por: Moradi, Luke A., et al.
Publicado: (2021)

Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
por: Xu, Yanjie, et al.
Publicado: (2022)

Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report
por: Chen, Cui, et al.
Publicado: (2022)

Characteristics of macrophage-like cells in acute nonarteritic anterior ischemic optic neuropathy and the normal fellow eyes on en face optical coherence tomography
por: Wang, Wenyu, et al.
Publicado: (2022)

The role of neuroimmune and inflammation in pediatric uremia-induced neuropathy
por: Zhu, Linfeng, et al.
Publicado: (2022)

Pembrolizumab induced pericardial tamponade: A case report
por: Uczkowski, Dariusz, et al.
Publicado: (2023)

Pembrolizumab-induced acute thrombosis: A case report
por: Kunimasa, Kei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j5ffh9cljmm90tb9rfcbvbh4th